What are the alternative names (generic and brand) for hyoscine (hyoscyamine) and dicyclomine (Bentyl)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Alternative Names for Hyoscine and Dicyclomine

Hyoscine Alternative Names

Hyoscine is also known as scopolamine, hyoscyamine, and hyoscine butylbromide 1, 2. The most common brand name is Buscopan 1, 2. Another brand formulation is Hyosyne (hyoscyamine sulfate) 3.

Important Nomenclature Clarification

There is some confusion in the literature regarding these terms:

  • Hyoscine butylbromide (scopolamine butylbromide) is the most commonly referenced form, marketed as Buscopan 2
  • Hyoscine hydrobromide is another salt form with similar anticholinergic properties 4
  • The terms "hyoscine," "scopolamine," and "hyoscyamine" are used somewhat interchangeably in clinical practice, though they may refer to slightly different chemical formulations 1, 5

Dicyclomine Alternative Names

Dicyclomine hydrochloride is most commonly known by the brand name Bentyl 6, 7. The chemical name is [bicyclohexyl]-1-carboxylic acid, 2-(diethylamino) ethylester, hydrochloride 6.

Key Clinical Context

Both medications are antispasmodic agents used for abdominal pain:

  • Hyoscine and dicyclomine are among the only antispasmodics available in the United States for treating irritable bowel syndrome 8
  • Both are antimuscarinic/anticholinergic agents that work by reducing smooth muscle contraction in the gastrointestinal tract 8, 6, 2
  • Dicyclomine is available as 20 mg tablets for oral administration 6
  • Hyoscine butylbromide (Buscopan) has very low systemic bioavailability (<1%) after oral administration, exerting primarily local effects 2

Critical Safety Note

Dicyclomine should never be administered intravenously due to risk of thrombosis 9. It is approved only for intramuscular or oral administration 6, 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.